Projects per year
Fingerprint
Dive into the research topics where Niels Vandewalle is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
THE IMPACT OF BETA-BLOCKERS ON MULTIPLE MYELOMA CELL SURVIVAL
Satilmis, H., Vandewalle, N., Fan, R., Oudaert, I. & De Veirman, K., 3 Mar 2021.Research output: Unpublished contribution to conference › Poster
-
THE IMPACT OF BETA-BLOCKERS ON MULTIPLE MYELOMA CELL SURVIVAL
Satilmis, H., Vandewalle, N., Fan, R., Oudaert, I. & De Veirman, K., 29 Jan 2020.Research output: Unpublished contribution to conference › Poster
-
AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma
Yan, S., Vandewalle, N., De Beule, N., Faict, S., Maes, K., De Bruyne, E., Menu, E., Vanderkerken, K. & De Veirman, K., 5 Nov 2019, In : Cancers. 11, 11, p. 1-17 17 p., 1727.Research output: Contribution to journal › Scientific review
Open Access10 Citations (Scopus)
Activities
- 2 Talk or presentation at a conference
-
AXL: A potential therapeutic target to eliminate cancer cells and improve chemotherapeutic responses in different hematological cancers
Niels Vandewalle (Contributor), Kim De Veirman (Speaker)14 Feb 2020Activity: Talk or presentation › Talk or presentation at a conference
-
AXL: A potential therapeutic target to improve chemosensitivity in Multiple Myeloma (BACR Annual Meeting 2020)
Kim De Veirman (Contributor), Niels Vandewalle (Speaker)7 Feb 2020Activity: Talk or presentation › Talk or presentation at a conference
Thesis
-
Targeting AXL, by small molecule inhibitors and Nanobody-based approaches, to eliminate cancer cells and improve chemotherapeutic responses in Acute Myeloid Leukemia
Author: De Veirman, K., Devoogdt, N., Breckpot, K. & Vandewalle, N., 18 Jun 2020Student thesis: Master's Thesis